Reference

1. ^Jain, K. K. (2004). „Modulators of nicotinic acetylcholine receptors as analgesics”.Current opinion in investigational drugs (London, England : 2000).5 (1): 76—81.PMID 14983978. 
2. ^Bannon, A. W.; Decker, M. W.; Holladay, M. W.; Curzon, P.; Donnelly-Roberts, D.; Puttfarcken, P. S.; Bitner, R. S.; Diaz, A.; Dickenson, A. H. (1998).„Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors”.Science.279 (5347): 77—81.Bibcode:1998Sci...279...77B.PMID 9417028.doi:10.1126/science.279.5347.77. 
3. ^Holladay, M.; Wasicak, J.; Lin, N.; He, Y.; Ryther, K.; Bannon, A.; Buckley, M.; Kim, D.; Decker, M. (1998). „Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors”.Journal of Medicinal Chemistry.41 (4): 407—412.PMID 9484491.doi:10.1021/jm9706224. 

Spoljašnje veze